Publication 3/01/2005

Innate immune responses to adenoviral vector-mediated acute pancreatitis.

Shifrin AL, Chirmule N, Gao GP, Wilson JM, Raper SE

Pancreas

Publication 9/01/2003

Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer.

Raper SE, Chirmule N, Lee FS, Wivel NA, Bagg A, Gao GP, Wilson JM, Batshaw ML

Molecular Genetics And Metabolism

Publication 10/10/2002

PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver.

Croyle MA, Chirmule N, Zhang Y, Wilson JM

Human Gene Therapy

Publication 1/01/2002

A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency.

Raper SE, Yudkoff M, Chirmule N, Gao GP, Nunes F, Haskal ZJ, Furth EE, Propert KJ, Robinson MB, Magosin S, Simoes H, Speicher L, Hughes J, Tazelaar J, Wivel NA, Wilson JM, Batshaw ML

Human Gene Therapy

Publication 7/01/2001

Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer.

Hildinger M, Auricchio A, Gao G, Wang L, Chirmule N, Wilson JM

Journal Of Virology

Publication 6/01/2001

Biology of E1-deleted adenovirus vectors in nonhuman primate muscle.

Zoltick PW, Chirmule N, Schnell MA, Gao GP, Hughes JV, Wilson JM

Journal Of Virology